Reducing Tobacco Related Health Disparities
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 23, 2009 | ||||
| Last Updated Date | April 25, 2013 | ||||
| Start Date ICMJE | January 2011 | ||||
| Estimated Primary Completion Date | July 2014 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Number of Patients with Tobacco Abstinence [ Time Frame: Assessments will occur at Baseline and at 6, 12, 18, and 24 months after Baseline. ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE |
Abstinence from Tobacco [ Time Frame: Assessments will occur at Baseline and at 6, 12, 18, and 24 months after Baseline. ] [ Designated as safety issue: No ] | ||||
| Change History | Complete list of historical versions of study NCT00984724 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Reducing Tobacco Related Health Disparities | ||||
| Official Title ICMJE | Reducing Tobacco Related Health Disparities | ||||
| Brief Summary | The goal of this research study is to learn the effectiveness of telephone-based counseling on helping smokers change their smoking patterns. Objectives: The specific aims are to:
|
||||
| Detailed Description | Researchers want to learn if telephone counseling can help smokers change their smoking patterns, when combined with other interventions. Study Groups: During the first (baseline) visit, you will be randomly assigned (as in a throw of the dice) to 1 of 6 possible study groups. The first group will receive free self-help materials, and a referral to the Quitline. The Quitline provides free quit smoking services to eligible callers. The second group will receive free self-help materials, a referral to the Quitline, and 300 pieces of nicotine gum at baseline. The third group will receive free self-help materials, a referral to the Quitline, and 6 telephone counseling sessions over the next 2 years. The fourth group will receive free self-help materials, a referral to the Quitline, 6 telephone counseling sessions over the next 2 years, and 300 pieces of nicotine gum at baseline. The fifth group will receive free self-help materials, a referral to the Quitline, and 12 telephone counseling sessions over the next 2 years. Finally, the sixth group will receive free self-help materials, a referral to the Quitline, 12 telephone counseling sessions over the next 2 years, and 300 pieces of nicotine gum at baseline. All participants, regardless of assigned group, will also receive up to 600 pieces of nicotine gum upon request when they are ready to try to quit smoking. This is in addition to the 300 pieces of gum some participants will receive at the baseline visit. Study Visits: If you choose to take part in this study, you will visit M. D. Anderson up to 5 times. Your first visit is the "baseline" visit when you enter the study. You will then be asked to come back for 4 follow-up visits at 6, 12, 18, and 24 months after enrolling in the study. Study Tests: The following tests and procedures will be performed at the study visits:
All participants will be contacted by mail or telephone throughout the length of the study. You may be contacted by mail, telephone, and/or e-mail during the study and follow-up, to be given reminders of clinic visits. You will be asked to provide the names and contact information for family and/or friends for the study staff to contact if the study staff has trouble reaching you. Genetic Testing: As part of this study, you will be asked to provide a saliva sample that will be collected at the first visit. To collect the saliva sample, you will be spitting into a container. Researchers will perform genetic tests with these samples to look for genes that control the production and use of neurotransmitters, naturally occurring chemical messengers in the brain. People with certain genes may have a more difficult time quitting smoking, because of the way nicotine affects these chemicals. The saliva sample will be stored in a biorepository at M. D. Anderson for use in future research related to nicotine addiction, smoking, and/or cancer. Your saliva sample will be placed in a bank of biological samples and data that is available to researchers conducting research related to cancer or nicotine dependence. Before your saliva sample can be used for research, the people doing the research must get specific approval from the Institutional Review Board (IRB) of M. D. Anderson. The IRB is a committee made up of doctors, researchers, and members of the community. The IRB is responsible for protecting the participants involved in research studies and making sure all research is done in a safe and ethical manner. All research done at M. D. Anderson, including research involving your saliva sample from this bank, must first be approved by the IRB. Your samples will be given a code number. No identifying information will be directly linked to your samples. Only the researcher in charge of the bank will have access to the code numbers and be able to link the samples to you. Other researchers using your samples will not be able to link this data to you. Genetic information obtained will not be provided to you. Telephone Counseling: The telephone counseling sessions will be digitally recorded. The recordings, if not destroyed, may be kept for use in future research studies. The recordings will be used to help the researchers make sure that the counselors are following the correct procedures and may be used in the future to help the investigators better understand or improve the counseling treatment. No one but the study investigators and their staff will be allowed to view or listen to the recordings, and the identity of the participants will be kept strictly confidential. Your study identification number will be stated by the counselor at the beginning of the taped session. The recordings are stored digitally, encrypted, and password protected. This is an investigational study. The nicotine gum used in this study is approved by the FDA. Up to 1000 smokers will take part in this research study. All will be enrolled at M. D. Anderson. |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Treatment |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Active, not recruiting | ||||
| Estimated Enrollment ICMJE | 1000 | ||||
| Completion Date | Not Provided | ||||
| Estimated Primary Completion Date | July 2014 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00984724 | ||||
| Other Study ID Numbers ICMJE | 2009-0372, 1R01CA141613-01 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | M.D. Anderson Cancer Center | ||||
| Study Sponsor ICMJE | M.D. Anderson Cancer Center | ||||
| Collaborators ICMJE | National Cancer Institute (NCI) | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | M.D. Anderson Cancer Center | ||||
| Verification Date | April 2013 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||